2/2: IMPACt-LBP DCC
2/2:IMPACt-LBP DCC
基本信息
- 批准号:10447570
- 负责人:
- 金额:$ 68.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-15 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAgeAmbulatory CareAmericanAmerican College of PhysiciansCaringCategoriesChronic low back painClinicClinicalClinical ResearchClinical Trials Data Monitoring CommitteesClinical Trials DesignClinical trial protocol documentCluster randomized trialCollaborationsDataData CollectionData Coordinating CenterData SetDoctor of ChiropracticEnsureEpidural InjectionsExerciseFeasibility StudiesFoundationsGoalsGuidelinesHealth Care CostsHealth systemHealthcare SystemsInfrastructureInterventionIowaLeadLinkLow Back PainManuscriptsMedicalMedical Care CostsMedical centerMethodsModelingMonitorMusculoskeletalMusculoskeletal PainNon-Steroidal Anti-Inflammatory AgentsOnline SystemsOpioidOrganizational PolicyOutcomePainPain interferencePain managementPain qualityPatient CarePatientsPhasePhysical FunctionPhysiciansPilot ProjectsPoliciesPreparationProceduresProviderPublicationsRandomized Clinical TrialsReportingResearch InstituteResearch PersonnelResourcesRiskSafetySourceSpinal FusionSpinal ManipulationStatistical Data InterpretationSystemTechniquesTimeTrainingUniversitiesVisitWorkbasecare providerschronic paincollaborative carecommunity based participatory researchcomparative effectivenesscompare effectivenesscostdata disseminationdata managementdata qualitydesigndisabilitydisability impacteffectiveness evaluationelectronic data capture systemexperiencefuture implementationhealth care service utilizationimplementation facilitationimplementation trialimprovedinnovationmeetingsmembermultidisciplinaryopioid epidemicopioid mortalityopioid usepain patientpain reductionphysical therapistpragmatic trialprescription opioidprocess evaluationpublic repositorysecondary endpointservice utilizationstandard caretreatment as usualweb site
项目摘要
Low back pain (LBP) is a key source of medical costs and disability, impacting over 31 million Americans at
any given time and resulting in $100-$200 billion per year in total healthcare costs. LBP is one of the leading
causes of ambulatory care visits to US physicians; unfortunately, these visits often result in treatments such as
opioids that can lead to more harm than benefit. In 2017 the American College of Physicians (ACP) guideline
for LBP recommended patients receive non-pharmacological interventions as a first-line treatment but stopped
short of offering solutions regarding how such treatments should be integrated into routine patient care.
Roadmaps exist for multi-disciplinary collaborative care that includes doctors of chiropractic and physical
therapists, well-trained primary contact clinicians with specific expertise in the treatment of musculoskeletal
conditions, as first line providers for LBP. These clinicians routinely employ many of the non-pharmacological
approaches recommended by the ACP guideline, including spinal manipulation and exercise. Important
foundational work conducted by members of the study team has demonstrated that such care is feasible, safe,
and results in improved physical function, less pain, fewer opioid prescriptions, and reduced utilization of
healthcare services. However, this treatment approach for LBP has yet to be widely implemented or validated
using rigorous scientific methods. Our overarching goal is to refine and implement a multidisciplinary
collaborative care model for LBP (MC2LBP) in 3 academic Health Care Systems (HCS) and then evaluate its
effectiveness by comparing it to usual medical care in patients age 18 and older suffering from LBP.
Completion of project study aims will begin with a one-year UG3 planning phase involving completion of 22
milestones in 2 categories of phased activities - model implementation and clinical trial design. UH3 study aims
will be accomplished using a pragmatic, cluster-randomized, clinical trial design. The study will be managed
through a Clinical Coordinating Center and Data Coordinating Center, both housed at the Duke Clinical
Research Institute, in collaboration with Dartmouth-Hitchcock Medical Center and the University of Iowa.
During the planning phase, we will build implementation infrastructure across three HCS, finalize the clinical
trial protocol, and complete the tasks necessary to transition from the UG3 to UH3 phase. The UH3 phase will
be used to: 1) Operationalize the integration of new organizational policies and procedures required to facilitate
implementation of MC2LBP at intervention clinics; 2) Determine the comparative effectiveness of MC2LBP vs
usual care; 3) Estimate and compare medical resource use and costs of implementing MC2LBP; and 4)
Evaluate patient, provider, system and policy level barriers and facilitators to implementing MC2LBP, using a
mixed method, process evaluation approach. Results from this study have the potential to inform future
implementation and policy efforts to improve the quality of pain management for patients suffering from LBP
while simultaneously reducing opioid prescriptions, health care costs and utilization of services.
腰痛 (LBP) 是医疗费用和残疾的一个重要根源,影响着超过 3100 万美国人
任何特定时间,每年都会产生 100 至 2000 亿美元的医疗保健总成本。 LBP 是领先的之一
美国医生门诊就诊的原因;不幸的是,这些访问通常会导致诸如以下的治疗:
阿片类药物弊大于利。 2017年美国医师学会(ACP)指南
对于腰痛,建议患者接受非药物干预作为一线治疗,但停止了
缺乏关于如何将此类治疗纳入常规患者护理的解决方案。
存在多学科协作护理的路线图,其中包括脊椎按摩医生和物理医生
治疗师、训练有素的主要接触临床医生,在肌肉骨骼治疗方面具有特定的专业知识
条件,作为 LBP 的一线提供商。这些临床医生经常使用许多非药物手段
ACP 指南推荐的方法,包括脊柱推拿和锻炼。重要的
研究小组成员进行的基础工作表明,这种护理是可行的、安全的、
从而改善身体机能、减少疼痛、减少阿片类药物处方并减少阿片类药物的使用
医疗保健服务。然而,这种腰痛治疗方法尚未得到广泛实施或验证
使用严格的科学方法。我们的总体目标是完善和实施多学科
3 个学术医疗保健系统 (HCS) 中的 LBP (MC2LBP) 协作护理模型,然后评估其
通过将其与 18 岁及以上 LBP 患者的常规医疗护理进行比较来确定其有效性。
项目研究目标的完成将从为期一年的 UG3 规划阶段开始,其中包括完成 22
两类分阶段活动的里程碑——模型实施和临床试验设计。 UH3研究目标
将使用务实的整群随机临床试验设计来完成。该研究将被管理
通过位于杜克临床中心的临床协调中心和数据协调中心
研究所与达特茅斯-希区柯克医学中心和爱荷华大学合作。
在规划阶段,我们将在三个 HCS 上建立实施基础设施,最终确定临床
试验方案,并完成从 UG3 过渡到 UH3 阶段所需的任务。 UH3阶段将
用于: 1) 实施整合新的组织政策和程序,以促进
在干预诊所实施 MC2LBP; 2) 确定 MC2LBP 与
日常护理; 3) 估计并比较医疗资源的使用和实施 MC2LBP 的成本;和 4)
使用以下方法评估实施 MC2LBP 的患者、提供者、系统和政策层面的障碍和促进因素:
混合法、过程评价法。这项研究的结果有可能为未来提供信息
提高 LBP 患者疼痛管理质量的实施和政策努力
同时减少阿片类药物处方、医疗保健成本和服务利用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Hrishikesh Chakraborty其他文献
Hrishikesh Chakraborty的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Hrishikesh Chakraborty', 18)}}的其他基金
The IGNITE II CC: Engagement, Coordination, Demonstration, and Dissemination
IGNITE II CC:参与、协调、示范和传播
- 批准号:
10827791 - 财政年份:2023
- 资助金额:
$ 68.98万 - 项目类别:
The IGNITE II CC: Engagement, Coordination, Demonstration, and Dissemination
IGNITE II CC:参与、协调、示范和传播
- 批准号:
10557379 - 财政年份:2022
- 资助金额:
$ 68.98万 - 项目类别:
Biomarkers of Dietary Intake and Exposure Data Coordinating Center
膳食摄入和暴露生物标志物数据协调中心
- 批准号:
10649583 - 财政年份:2021
- 资助金额:
$ 68.98万 - 项目类别:
Biomarkers of Dietary Intake and Exposure Data Coordinating Center
膳食摄入和暴露生物标志物数据协调中心
- 批准号:
10286935 - 财政年份:2021
- 资助金额:
$ 68.98万 - 项目类别:
Biomarkers of Dietary Intake and Exposure Data Coordinating Center
膳食摄入和暴露生物标志物数据协调中心
- 批准号:
10461148 - 财政年份:2021
- 资助金额:
$ 68.98万 - 项目类别:
2/2 Kids MoD PAH Trial: Mono- vs. Duo-Therapy for Pediatric Pulmonary Arterial Hypertension-DCC
2/2 儿童国防部 PAH 试验:小儿肺动脉高压 - DCC 的单一疗法与双重疗法
- 批准号:
10214114 - 财政年份:2021
- 资助金额:
$ 68.98万 - 项目类别:
2/2 Kids MoD PAH Trial: Mono- vs. Duo-Therapy for Pediatric Pulmonary Arterial Hypertension-DCC
2/2 儿童国防部 PAH 试验:小儿肺动脉高压 - DCC 的单一疗法与双重疗法
- 批准号:
10486005 - 财政年份:2021
- 资助金额:
$ 68.98万 - 项目类别:
The IGNITE II CC: Engagement, Coordination, Demonstration, and Dissemination
IGNITE II CC:参与、协调、示范和传播
- 批准号:
10418650 - 财政年份:2018
- 资助金额:
$ 68.98万 - 项目类别:
相似国自然基金
HTRA1介导CTRP5调控脂代谢通路在年龄相关性黄斑变性中的致病机制研究
- 批准号:82301231
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
PLAAT3降低介导线粒体降解异常在年龄相关性白内障发病中的作用及机制
- 批准号:82301190
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
跨尺度年龄自适应儿童头部模型构建与弥漫性轴索损伤行为及表征研究
- 批准号:52375281
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
ALKBH5通过SHP-1调控视网膜色素上皮细胞铁死亡在年龄相关性黄斑变性中的作用机制研究
- 批准号:82301213
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
视网膜色素上皮细胞中NAD+水解酶SARM1调控自噬溶酶体途径参与年龄相关性黄斑变性的机制研究
- 批准号:82301214
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Smartphone-based mindfulness intervention for reducing stressrelated CVD risk
基于智能手机的正念干预可降低压力相关的心血管疾病风险
- 批准号:
10593307 - 财政年份:2023
- 资助金额:
$ 68.98万 - 项目类别:
Social Media Signals for reducing Perinatal Death by Suicide
减少围产期自杀死亡的社交媒体信号
- 批准号:
10575210 - 财政年份:2023
- 资助金额:
$ 68.98万 - 项目类别:
Identifying Risk Factors for Poor Glycemic Control among Emergency Department Patients and Improving Linkage to Outpatient Care
确定急诊科患者血糖控制不佳的风险因素并改善与门诊护理的联系
- 批准号:
10734304 - 财政年份:2023
- 资助金额:
$ 68.98万 - 项目类别:
Development and Evaluation of an Avatar Guided Mobile Health for Emerging Adults
针对新兴成年人的化身引导移动健康的开发和评估
- 批准号:
10843991 - 财政年份:2023
- 资助金额:
$ 68.98万 - 项目类别: